These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 29111294)

  • 1. Oxygen binding isotope effects of triazole-based HIV-1 reverse transcriptase inhibitors indicate the actual binding site.
    Krzemińska A; Frączek T; Paneth P
    Arch Biochem Biophys; 2017 Dec; 635():87-95. PubMed ID: 29111294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Theoretical studies of energetics and binding isotope effects of binding a triazole-based inhibitor to HIV-1 reverse transcriptase.
    Krzemińska A; Świderek KP; Paneth P
    Phys Chem Chem Phys; 2016 Jan; 18(1):310-7. PubMed ID: 26612030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding isotope effects as a tool for distinguishing hydrophobic and hydrophilic binding sites of HIV-1 RT.
    Krzemińska A; Paneth P; Moliner V; Świderek K
    J Phys Chem B; 2015 Jan; 119(3):917-27. PubMed ID: 25132465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Searching for novel scaffold of triazole non-nucleoside inhibitors of HIV-1 reverse transcriptase.
    Frączek T; Paneth A; Kamiński R; Krakowiak A; Paneth P
    J Enzyme Inhib Med Chem; 2016; 31(3):481-9. PubMed ID: 25942362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing molecular docking tools for relative biological activity prediction: a case study of triazole HIV-1 NNRTIs.
    Frączek T; Siwek A; Paneth P
    J Chem Inf Model; 2013 Dec; 53(12):3326-42. PubMed ID: 24266618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular docking studies on 4-thiazolidinones as HIV-1 RT inhibitors.
    Rawal RK; Kumar A; Siddiqi MI; Katti SB
    J Mol Model; 2007 Jan; 13(1):155-61. PubMed ID: 16969668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Theoretical studies of HIV-1 reverse transcriptase inhibition.
    Świderek K; Martí S; Moliner V
    Phys Chem Chem Phys; 2012 Sep; 14(36):12614-24. PubMed ID: 22820901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Per-residue energy decomposition pharmacophore model to enhance virtual screening in drug discovery: a study for identification of reverse transcriptase inhibitors as potential anti-HIV agents.
    Cele FN; Ramesh M; Soliman ME
    Drug Des Devel Ther; 2016; 10():1365-77. PubMed ID: 27114700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pharmacophore docking algorithm and its application to the cross-docking of 18 HIV-NNRTI's in their binding pockets.
    Daeyaert F; de Jonge M; Heeres J; Koymans L; Lewi P; Vinkers MH; Janssen PA
    Proteins; 2004 Feb; 54(3):526-33. PubMed ID: 14748000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular basis of resilience to the effect of the Lys103Asn mutation in non-nucleoside HIV-1 reverse transcriptase inhibitors studied by targeted molecular dynamics simulations.
    Rodríguez-Barrios F; Balzarini J; Gago F
    J Am Chem Soc; 2005 May; 127(20):7570-8. PubMed ID: 15898808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissecting the effects of DNA polymerase and ribonuclease H inhibitor combinations on HIV-1 reverse-transcriptase activities.
    Shaw-Reid CA; Feuston B; Munshi V; Getty K; Krueger J; Hazuda DJ; Parniak MA; Miller MD; Lewis D
    Biochemistry; 2005 Feb; 44(5):1595-606. PubMed ID: 15683243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of the binding free energies of new TIBO-like HIV-1 reverse transcriptase inhibitors using a combination of PROFEC, PB/SA, CMC/MD, and free energy calculations.
    Eriksson MA; Pitera J; Kollman PA
    J Med Chem; 1999 Mar; 42(5):868-81. PubMed ID: 10072684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, biological evaluation and molecular modeling studies of N-aryl-2-arylthioacetamides as non-nucleoside HIV-1 reverse transcriptase inhibitors.
    Xiaohe Z; Yu Q; Hong Y; Xiuqing S; Rugang Z
    Chem Biol Drug Des; 2010 Oct; 76(4):330-9. PubMed ID: 20731670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triazole derivatives as non-nucleoside inhibitors of HIV-1 reverse transcriptase--structure-activity relationships and crystallographic analysis.
    Kirschberg TA; Balakrishnan M; Huang W; Hluhanich R; Kutty N; Liclican AC; McColl DJ; Squires NH; Lansdon EB
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1131-4. PubMed ID: 18083512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-reverse transcriptase inhibition: inclusion of ligand-induced fit by cross-docking studies.
    Ragno R; Frasca S; Manetti F; Brizzi A; Massa S
    J Med Chem; 2005 Jan; 48(1):200-12. PubMed ID: 15634014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and biological evaluation of 1,3-diarylpropenones as dual inhibitors of HIV-1 reverse transcriptase.
    Meleddu R; Cannas V; Distinto S; Sarais G; Del Vecchio C; Esposito F; Bianco G; Corona A; Cottiglia F; Alcaro S; Parolin C; Artese A; Scalise D; Fresta M; Arridu A; Ortuso F; Maccioni E; Tramontano E
    ChemMedChem; 2014 Aug; 9(8):1869-79. PubMed ID: 24850787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unconventional plasticity of HIV-1 reverse transcriptase: how inhibitors could open a connection "gate" between allosteric and catalytic sites.
    Bellucci L; Angeli L; Tafi A; Radi M; Botta M
    J Chem Inf Model; 2013 Dec; 53(12):3117-22. PubMed ID: 24256065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, biochemical, and antiviral evaluations of C6 benzyl and C6 biarylmethyl substituted 2-hydroxylisoquinoline-1,3-diones: dual inhibition against HIV reverse transcriptase-associated RNase H and polymerase with antiviral activities.
    Vernekar SK; Liu Z; Nagy E; Miller L; Kirby KA; Wilson DJ; Kankanala J; Sarafianos SG; Parniak MA; Wang Z
    J Med Chem; 2015 Jan; 58(2):651-64. PubMed ID: 25522204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular dynamics simulations of 2-amino-6-arylsulphonylbenzonitriles analogues as HIV inhibitors: interaction modes and binding free energies.
    Hu R; Barbault F; Maurel F; Delamar M; Zhang R
    Chem Biol Drug Des; 2010 Dec; 76(6):518-26. PubMed ID: 20942836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory Effect of 2,3,5,6-Tetrafluoro-4-[4-(aryl)-1H-1,2,3-triazol-1-yl]benzenesulfonamide Derivatives on HIV Reverse Transcriptase Associated RNase H Activities.
    Pala N; Esposito F; Rogolino D; Carcelli M; Sanna V; Palomba M; Naesens L; Corona A; Grandi N; Tramontano E; Sechi M
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27556447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.